EDGAR Filing Documents for 0001493152-23-011145

Form 8-K - Current report:

SEC Accession No. 0001493152-23-011145

Filing Date

2023-04-06

Accepted

2023-04-06 10:10:05

Documents

Period of Report

2023-03-31

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	43848
2		ex10-1.htm	EX-10.1	174930
3		ex99-1.htm	EX-99.1	14446
	Complete submission text file	0001493152-23-011145.txt		446363

Data Files

Seq	Description	Document	Type	Size
4	XBRL SCHEMA FILE	bstg-20230331.xsd	EX-101.SCH	3227
5	XBRL LABEL FILE	bstg-20230331_lab.xml	EX-101.LAB	34240
6	XBRL PRESENTATION FILE	bstg-20230331_pre.xml	EX-101.PRE	22359
8	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3165

Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746

Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300

Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)